TAKE2
LIVE

Serial Number

97261874

Owner

Take2 Health Limited

Attorney

Tama L. Drenski

Filing Date

Feb 10, 2022

Add to watchlist:

No watchlists yet
View on USPTO

TAKE2 Trademark

Serial Number: 97261874 • Registration: 7283042

TAKE2 is a trademark filed by Take2 Health Limited on February 10, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Take2 Health Limited (2 trademarks)

21/F, Edinburgh Tower
Hong Kong , HK

Entity Type: 99

Trademark Details

Filing Date

February 10, 2022

Registration Date

January 23, 2024

Published for Opposition

September 19, 2023

Goods & Services

(Based on 44(e)) Automated laboratory apparatus for use in analysis of biomolecules for scientific purposes; nucleic acid sequencers for scientific purposes; non-medical imaging devices for gemstones, roots, for clinical diagnostic purposes and scientific research; laboratory equipment, namely, cupels, funnels, microarrays, and electric bath heaters; scientific equipment and instruments, namely, ultra-high vacuum champers and scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; DNA testing apparatus which carry or hold DNA samples for non-medical purposes; Ophthalmic instruments, namely, ophthalmic lenses

(Based on 44(e)) Pharmaceutical, medical and veterinary preparations, namely, chemical preparations for pharmaceutical or medical purposes, namely, for treating cancer, medical preparations for the treatment of cancer, pharmaceutical products for the treatment of cancer; medical diagnostic reagents; clinical diagnostic reagents, namely, reagents for use in medical genetic testing; reagents, enzymes, and nucleotides for use in genetic testing for medical and diagnostic purposes, namely, reagents for medical use, diagnostic reagents for medical use, enzymes for medical purposes, reagents for medical use and medical diagnostic reagents, and screening kits comprised of reagents for medical diagnostics and for medical screening use; reagent kits composed of medical diagnostic reagents and medical diagnostic reagent beads with attached biomolecules for clinical diagnostic purposes; diagnostic tests and test kits for determination of genetic information for medical purposes, namely, genetic identity tests comprised of reagents for medical purposes; pharmaceutical products for ophthalmological use, for the treatment of cancer, for treating diabetes, for the treatment of bone disease; diagnostic medical reagents for medical use; medical diagnostic test kits, namely, medical diagnostic preparations and screening kits comprised of reagents for medical diagnostics and medical screening use, diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, namely, cancer

(Based on 44(e)) Chemicals used in industry and science; assays and reagents for scientific and research use, namely, assays and reagents for use in genetic research, assays for research purposes, reagents for scientific and research use; diagnostic reagents for scientific use; diagnostic preparations for scientific use; diagnostic test kits for use in the fields of scientific, pharmaceutical and medical research, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; diagnostic test kits for scientific use, namely, kits comprised of diagnostic reagents and preparations for scientific use; chemical reagents for non-medical purposes; chemical test kits for analysis and detection of genetic information and diseases for scientific, clinical or medical laboratory use; chemical reagents and kits containing same, each for scientific purposes; reagents, enzymes, and nucleotides for medical research use; Chemical preparations for pharmaceutical or medical purposes, namely, for chemical additives for use in the manufacture of pharmaceuticals for cancer

(Based on 44(e)) Surgical apparatus and instruments for medical use, namely, incubators for medical purposes, apparatus for use in medical analysis, namely, medical diagnostic instruments for the analysis of body fluids; and ophthalmic instruments, namely, lasers for ophthalmic purposes; medical diagnostic apparatus, namely, ultrasonic medical diagnostic apparatus and hematology analyzers for medical diagnostic uses; analytical apparatus for medical purposes, namely, medical instruments for analyzing bacteria and breath gas analyzers for medical diagnostics; medical apparatus for detecting cancer; cholesterol meters; endoscopic equipment for medical purposes; enema apparatus for medical purposes; physical exercise apparatus, for medical purposes; gloves for medical purposes; magnetic resonance imaging apparatus for medical purposes; massage apparatus for medical purposes; medical apparatus and instruments for detecting and treating cancer; DNA testing apparatus which carry or hold DNA samples for medical purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 23, 2024 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 23, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 23, 2024 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Dec 14, 2023 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 14, 2023 AITU
NOTICE OF ALLOWANCE CANCELLED
Nov 14, 2023 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Nov 14, 2023 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 14, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 19, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 19, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 30, 2023 NONP
CASE RETURNED TO EXAMINATION
Aug 16, 2023 OTHE
NOTICE OF ALLOWANCE CANCELLED
Aug 16, 2023 IUCN
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 11, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 16, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 16, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 26, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 10, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 15, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 13, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 13, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 21, 2022 GNRN
NON-FINAL ACTION E-MAILED
Nov 21, 2022 GNRT
NON-FINAL ACTION WRITTEN
Nov 21, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 26, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 26, 2022 CRFA
ASSIGNED TO LIE
Oct 25, 2022 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 14, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 22, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 22, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 22, 2022 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 22, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 22, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 22, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 18, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 15, 2022 NWOS
NEW APPLICATION ENTERED
Feb 14, 2022 NWAP